Exelixis Inc (EXEL) concluded trading on Wednesday at a closing price of $32.44, with 6.74 million shares of worth about $218.58 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 47.96% during that period and on October 30, 2024 the price saw a gain of about 12.91%. Currently the company’s common shares owned by public are about 302.79M shares, out of which, 277.90M shares are available for trading.
Stock saw a price change of 14.55% in past 5 days and over the past one month there was a price change of 23.35%. Year-to-date (YTD), EXEL shares are showing a performance of 35.22% which increased to 60.28% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $19.20 but also hit the highest price of $29.75 during that period. The average intraday trading volume for Exelixis Inc shares is 1.98 million. The stock is currently trading 16.80% above its 20-day simple moving average (SMA20), while that difference is up 20.96% for SMA50 and it goes to 37.41% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Exelixis Inc (NASDAQ: EXEL) currently have 302.79M outstanding shares and institutions hold larger chunk of about 85.89% of that.
The stock has a current market capitalization of $9.25B and its 3Y-monthly beta is at 0.55. PE ratio of stock for trailing 12 months is 20.67, while it has posted earnings per share of $1.57 in the same period. Its PEG reads 0.69 and has Quick Ratio of 3.88 while making debt-to-equity ratio of 0.09. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EXEL, volatility over the week remained 3.13% while standing at 3.01% over the month.
Stock’s fiscal year EPS is expected to rise by 155.42% while it is estimated to decrease by -0.49% in next year. EPS is likely to grow at an annualized rate of 29.92% for next 5-years, compared to annual growth of -21.77% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by RBC Capital Mkts on October 16, 2024 offering an Outperform rating for the stock and assigned a target price range of between $30 and $34 to it. Coverage by UBS stated Exelixis Inc (EXEL) stock as a Neutral in their note to investors on September 19, 2024, suggesting a price target of $30 for the stock. On April 11, 2024, Barclays Downgrade their recommendations, while on December 19, 2023, BTIG Research Initiated their ratings for the stock with a price target of $27. Stock get a Buy rating from Citigroup on December 15, 2023.
